IL-1 is the strongest known activator of human astrocytes and human glioma cells, suggesting that aberrant innate immune interactions involving IL-1 could have significant impact on glioma progression and the integrity of CNS tissue. The gene discussed is IL1A; the disease is central nervous system cancer.